Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease 3. Rapid correction of low vitamin D status in nursing home residents 4. 2008 Exclusive Survey—Earnings: Good news for primary care income 5. Medicare pay-for-reporting effort draws fire from frustrated doctors
Your Article Summary
See Latest ArticlesA selective endothelin-receptor antagonist to reduce blood pressure in patients with treatment-resistant hypertension: a randomised, double-blind, placebo-controlled trial
The Lancet, 10/27/09
Weber MA et al. – Darusentan provides additional reduction in blood pressure in patients who have not attained their treatment goals with three or more antihypertensive drugs. As with other vasodilatory drugs, fluid management with effective diuretic therapy might be needed.
Related Articles
Effective strategies for management of hypertension after vascular endothelial growth factor signaling inhibition therapy: Results from a phase II randomized, factorial, double-blind study of cediranib in patients with advanced solid tumors
Journal of Clinical Oncology, 11/13/09
Relevance Score: 94%
Practical strategies for management of hypertension in the elderly
Internet Source, 10/13/09
Relevance Score: 92%
Hypertension in Women: More Evidence for the Role of Lifestyle
Nursing for Women's Health, 10/12/09
Relevance Score: 92%
Hypertension treatment and management concerns in the elderly
Aging Health, 10/07/09
Relevance Score: 92%
Intradialytic Hypertension: A Less-Recognized Cardiovascular Complication of Hemodialysis
American Journal of Kidney Diseases, 10/28/09
Relevance Score: 91%
Today in Hypertension...keeping you current
Receive free subspecialty "5-minute updates" via email
A maternal but not paternal association of ambulatory blood pressure with albumin excretion in young offspring with type 1 diabetes
Diabetes Care, 11/20/09
Predictors of Hypertension Following Successful Renal Transplantation: A Population-Based Study
Transplantation Proceedings, 11/20/09
Do COX-2 inhibitors raise blood pressure more than nonselective NSAIDs and placebo? An updated meta-analysis
Journal of Hypertension, 11/20/09
Sponsor
Article Search
Sponsor